Walter et al. observed a significantly higher RASSF1A methylation level in SCLC and large cell neuroendocrine carcinomas than in NSCLC, suggesting it could be a potential marker for differential diagnosis [130]. The gene discussed is RASSF1; the disease is non-small cell lung carcinoma.